Metastatic cancer is stage 4, the most advanced stage in the standard cancer staging system. This means cancer cells have spread from where they originally started to a distant part of the body, such as the bones, liver, lungs, or brain. For most solid tumors, the moment distant spread is confirmed, the cancer is classified as stage 4 regardless of the size of the original tumor or how many lymph nodes are involved.
One detail that often confuses people: metastatic cancer keeps the name of the original cancer. Breast cancer that spreads to the lungs is still breast cancer, staged and treated as stage 4 breast cancer, not lung cancer. The cells in the lung are breast cancer cells, and they respond to breast cancer treatments.
How the Staging System Works
Most cancers are staged using a system called TNM, which stands for Tumor, Node, Metastasis. Each letter gets a number that describes how far the cancer has progressed. The T category measures the size and extent of the primary tumor. The N category indicates whether cancer has reached nearby lymph nodes. The M category is the one that determines metastatic status: M0 means no distant spread has been found, and M1 means it has.
An M1 classification automatically places most cancers at stage 4. For some cancer types, M1 is broken down further. In colorectal cancer, for example, M1a means the cancer has spread to one distant area, M1b means it has reached two or more areas, and M1c means it has spread to the lining of the abdominal cavity. These subcategories help oncologists tailor treatment more precisely, but they all fall under the stage 4 umbrella.
Not Every Cancer Uses This System
The stage 4 designation applies to most solid tumors: breast, lung, colon, prostate, and others. But blood cancers like leukemia and lymphoma don’t follow the same rules. These cancers are already in the blood or lymphatic system by nature, so the concept of “spreading to a distant site” doesn’t apply the same way. Lymphomas have their own staging systems based on how many lymph node groups are involved and whether organs outside the lymphatic system are affected. Leukemia is typically classified by cell type and how quickly it progresses rather than by stage numbers.
Brain tumors are another exception. They rarely spread outside the brain and spinal cord, so they’re graded on a scale from 1 to 4 based on how abnormal the cells look and how fast they grow, not on whether they’ve metastasized.
How Cancer Spreads to Distant Sites
Cancer cells reach distant organs through two main routes: the bloodstream and the lymphatic system. Lymphatic vessels are “leakier” than blood vessels because they lack the tight seals and protective layers that blood vessel walls have. This makes it easier for cancer cells to slip into lymphatic fluid. Once inside the lymphatic system, cells can eventually drain into the bloodstream through large veins near the collarbone, giving them access to the entire body.
Cancer cells can also enter blood vessels directly. Research using imaging of tumors in animals has shown that metastatic cells actively move toward blood vessels, using a type of amoeba-like crawling motion to push through vessel walls. Some cancer cells travel as clusters rather than individually, and these clumps appear to be more efficient at establishing new tumors when they land in a distant organ.
The process is surprisingly inefficient. Most cancer cells that enter the bloodstream don’t survive the journey. They’re destroyed by the immune system, damaged by the physical forces of circulation, or simply fail to take hold when they arrive somewhere new. But the ones that do survive can seed new tumors in organs that provide a favorable environment.
Oligometastatic Disease: A Middle Ground
Not all stage 4 cancers are the same. In the mid-1990s, researchers proposed that there’s an intermediate state between localized cancer and widespread metastatic disease. This state, called oligometastatic disease, involves only a small number of metastatic tumors, often in just one or two locations.
This distinction matters because oligometastatic disease can sometimes be treated more aggressively. Patients with a limited number of metastatic spots may benefit from targeted radiation or surgery to remove those specific tumors, in addition to standard systemic treatment. Clinical trials have shown that adding these local treatments can improve both how long patients live and how long they go without the cancer progressing. Before this concept gained traction, metastatic disease was generally treated only with body-wide therapies like chemotherapy, since it was assumed that any visible spread meant the cancer was everywhere.
How Stage 4 Cancer Is Diagnosed
If your doctor suspects cancer has spread, several imaging tests can confirm it. A PET scan is one of the most useful because cancer cells consume more sugar than normal cells, and the scan highlights areas of high sugar uptake throughout the body. CT scans and MRIs provide detailed cross-sectional images that can reveal tumors in organs like the liver, brain, or lungs. Bone scans specifically look for cancer that has reached the skeleton, which is common in breast, prostate, and lung cancers.
A biopsy of the suspected metastatic site may also be done to confirm that the cells match the original cancer. This step is important because it rules out the possibility of a completely new, unrelated cancer and confirms the right treatment approach.
How Stage 4 Differs From Recurrence
People sometimes confuse metastatic cancer with cancer that has come back after treatment. These can overlap, but they’re not the same thing. A local recurrence means cancer has returned at or near the original site. A regional recurrence means it has grown into nearby lymph nodes or tissues. A distant recurrence means it has spread to far-off organs, and that is metastatic cancer. So a distant recurrence is stage 4, but a local recurrence may not be.
Treatment for Metastatic Cancer
Stage 4 cancer is primarily treated with systemic therapies, meaning treatments that reach cancer cells throughout the body. The three main categories are chemotherapy, targeted therapy, and immunotherapy. Chemotherapy remains the backbone of treatment for many cancer types, working by killing rapidly dividing cells. Targeted therapy uses drugs designed to block specific proteins that drive a particular cancer’s growth, and it tends to cause fewer side effects than traditional chemotherapy. Immunotherapy helps the immune system recognize and attack cancer cells that have been evading detection.
Many patients receive combinations of these approaches. Surgery and radiation can also play a role in stage 4 cancer, particularly for oligometastatic disease or to relieve symptoms like pain from a tumor pressing on a nerve or bone. The goal of treatment varies. In some cases, it aims to shrink tumors and extend life significantly. In others, the focus is on controlling growth and maintaining quality of life for as long as possible.
Survival Rates Vary Widely
Five-year survival rates for stage 4 cancer depend heavily on where the cancer originated. Stage 4 breast cancer has a five-year relative survival rate of about 31%. Stage 4 colon cancer drops to around 12%, while stage 4 rectal cancer is about 16%. Stage 4 lung cancer, which accounts for roughly half of all lung cancer diagnoses, has a five-year survival rate of approximately 6%.
These numbers, based on patients diagnosed between 2013 and 2017, don’t fully capture the impact of newer treatments that have entered practice since then, particularly immunotherapy and next-generation targeted drugs. Survival rates are population averages and can’t predict what will happen for any individual. Factors like the specific genetic makeup of the tumor, overall health, how well the cancer responds to treatment, and the number and location of metastases all influence outcomes. Some people with stage 4 cancer live years beyond what statistics suggest, especially as treatment options continue to expand.